To explore whether the decreased expression of MCL-1 and increased cell apoptosis after ABGE treatment were related to the ROS in ER+ breast cancer, we examined the mitochondrial and intracellular ROS levels in MCF-7 cells. Here, MCL1 is linked to breast cancer.